Cutia Therapeutics (2487.HK)

HKD 6.95

(0.14%)

Net Income Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual net income in 2023 was -1.96 Billion CNY , down -253.3% from previous year.
  • Cutia Therapeutics's latest quarterly net income in 2024 Q2 was -100.46 Million CNY , down 0.0% from previous quarter.
  • Cutia Therapeutics reported an annual net income of -555.83 Million CNY in 2022, down -73.93% from previous year.
  • Cutia Therapeutics reported an annual net income of -319.58 Million CNY in 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported a quarterly net income of -100.46 Million CNY for 2024 Q1, up 37.87% from previous quarter.
  • Cutia Therapeutics reported a quarterly net income of -161.7 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Net Income of Cutia Therapeutics (2023 - 2021)

Year Net Income Net Income Growth
2023 -1.96 Billion CNY -253.3%
2022 -555.83 Million CNY -73.93%
2021 -319.58 Million CNY 0.0%

Peer Net Income Comparison of Cutia Therapeutics

Name Net Income Net Income Difference
Uni-Bio Science Group Limited 70.87 Million HKD 2870.695%
CK Life Sciences Int'l., (Holdings) Inc. 17.25 Million HKD 11484.104%